AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 19.77 |
Market Cap | 2.52B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 0.11 |
PE Ratio (ttm) | 190.82 |
Forward PE | n/a |
Analyst | Buy |
Ask | 24.7 |
Volume | 238,244 |
Avg. Volume (20D) | 705,093 |
Open | 20.90 |
Previous Close | 20.74 |
Day's Range | 20.61 - 21.11 |
52-Week Range | 15.92 - 23.24 |
Beta | undefined |
About PRVA
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable...
Analyst Forecast
According to 16 analyst ratings, the average rating for PRVA stock is "Buy." The 12-month stock price forecast is $25, which is an increase of 19.10% from the latest price.
Next Earnings Release
Analysts project revenue of $422.58M, reflecting a -4.14% YoY shrinking and earnings per share of 0.2, making a 33.33% increase YoY.
2 months ago · seekingalpha.com
Privia Health Group, Inc. (PRVA) Q3 2024 Earnings Call TranscriptPrivia Health Group, Inc. (NASDAQ:PRVA ) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Robert Borchert - Senior Vice President- Investor & Corporate Communications ...